A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (YONDELIS®) in Patients with Localized Myxoid / Round Cell Liposarcoma

Update Il y a 4 ans
Reference: EUCTR2007-000035-25

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- To determine the pathological complete response (pCR) rate with trabectedin in patients with locally advanced (Stage III) myxoid / round cell liposarcoma (MRCL).


Inclusion criteria

  • Locally advanced (Stage III) myxoid / round cell liposarcoma previously untreated with chemotherapy or radiation